TY - JOUR
T1 - Down-regulation of G-protein-mediated Ca2+ sensitization in smooth muscle
AU - Gong, Ming Cui
AU - Fujihara, Hideyoshi
AU - Walker, Lori A.
AU - Somlyo, Avril V.
AU - Somlyo, Andrew P.
PY - 1997/2
Y1 - 1997/2
N2 - Prolonged treatment with guanosine 5'-[γ-thio]triphosphate (GTPγS; 5- 16 h, 50 μM) of smooth muscle permeabilized with Staphylococcus aureus α- toxin down-regulated (abolished) the acute Ca2+ sensitization of force by GTPγS, A1F4, phenylephrine, and endothelin, but not the response to phorbol dibutyrate or a phosphatase inhibitor, tautomycin. Down-regulation also abolished the GTPγS-induced increase in myosin light chain phosphorylation at constant [Ca2+] and was associated with extensive translocation of p21(rhoA) to the particulate fraction, prevented its immunoprecipitation, and inhibited its ADP ribosylation without affecting the immunodetectable content of G-proteins (p21(rhoA), p21(ras), G(αq/11), G(αi3), and G(β)) or protein kinase C (types α, β1, β2, δ, ε, η, θ, and ζ). We conclude that the loss of GTPγS- and agonist-induced Ca sensitization through prolonged treatment with GTPγS is not due to a decrease in the total content of either trimeric (G(αq/11), G(αi3), and G(β)) or monomeric (p21(rhoA)and p21(ras)) G-protein or protein kinase C but may be related to a structural change of p21(rhoA)and/or to down- regulation of its (yet to be identified) effector.
AB - Prolonged treatment with guanosine 5'-[γ-thio]triphosphate (GTPγS; 5- 16 h, 50 μM) of smooth muscle permeabilized with Staphylococcus aureus α- toxin down-regulated (abolished) the acute Ca2+ sensitization of force by GTPγS, A1F4, phenylephrine, and endothelin, but not the response to phorbol dibutyrate or a phosphatase inhibitor, tautomycin. Down-regulation also abolished the GTPγS-induced increase in myosin light chain phosphorylation at constant [Ca2+] and was associated with extensive translocation of p21(rhoA) to the particulate fraction, prevented its immunoprecipitation, and inhibited its ADP ribosylation without affecting the immunodetectable content of G-proteins (p21(rhoA), p21(ras), G(αq/11), G(αi3), and G(β)) or protein kinase C (types α, β1, β2, δ, ε, η, θ, and ζ). We conclude that the loss of GTPγS- and agonist-induced Ca sensitization through prolonged treatment with GTPγS is not due to a decrease in the total content of either trimeric (G(αq/11), G(αi3), and G(β)) or monomeric (p21(rhoA)and p21(ras)) G-protein or protein kinase C but may be related to a structural change of p21(rhoA)and/or to down- regulation of its (yet to be identified) effector.
UR - http://www.scopus.com/inward/record.url?scp=0001108447&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0001108447&partnerID=8YFLogxK
U2 - 10.1091/mbc.8.2.279
DO - 10.1091/mbc.8.2.279
M3 - Article
C2 - 9190207
AN - SCOPUS:0001108447
SN - 1059-1524
VL - 8
SP - 279
EP - 286
JO - Molecular Biology of the Cell
JF - Molecular Biology of the Cell
IS - 2
ER -